|
1
|
Omuro A and DeAngelis LM: Glioblastoma and
other malignant gliomas: A clinical review. JAMA. 310:1842–1850.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Stupp R and Hegi ME: Brain cancer in 2012:
Molecular characterization leads the way. Nat Rev Clin Oncol.
10:69–70. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Stupp R and Weber DC: The role of radio-
and chemotherapy in glioblastoma. Onkologie. 28:315–317.
2005.PubMed/NCBI
|
|
4
|
Soltanian S and Matin MM: Cancer stem
cells and cancer therapy. Tumour Biol. 32:425–440. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Tabatabai G and Weller M: Glioblastoma
stem cells. Cell Tissue Res. 343:459–465. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Taal W, Bromberg JE and van den Bent MJ:
Chemotherapy in glioma. CNS Oncol. 4:179–192. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Lathia JD, Mack SC, Mulkearns-Hubert EE,
Valentim CL and Rich JN: Cancer stem cells in glioblastoma. Genes
Dev. 29:1203–1217. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Zaridze DG: Carcinogenesis. Medicine;
Zaridze D.G.: pp. 1–567. 2004, PubMed/NCBI
|
|
9
|
Hide T, Makino K, Nakamura H, Yano S, Anai
S, Takezaki T, Kuroda J, Shinojima N, Ueda Y and Kuratsu J: New
treatment strategies to eradicate cancer stem cells and niches in
glioblastoma. Neurol Med Chir (Tokyo). 53:764–772. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Duesberg P, Mandrioli D, McCormack A and
Nicholson JM: Is carcinogenesis a form of speciation? Cell Cycle.
10:2100–2014. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Pecchia I, Dini V, Ricci-Vitiani L,
Biffoni M, Balduzzi M, Fratini E, Belli M, Campa A, Esposito G,
Cirrone G, et al: Glioblastoma stem cells: Radiobiological response
to ionising radiations of different qualities. Radiat Prot
Dosimetry. 166:374–378. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Bryukhovetskiy IS, Mischenko PV, Tolok EV,
Zaitcev SV, Khotimchenko YS and Bryukhovetskiy AS: Directional
migration of adult hematopoietic progenitors to C6 glioma in vitro.
Oncol Lett. 9:1839–1844. 2015.PubMed/NCBI
|
|
13
|
Bryukhovetskiy I, Bryukhovetsky A,
Khotimchenko Y, Mischenko P, Tolok E and Khotimchenko R:
Combination of the multipotent mesenchymal stromal cell
transplantation with administration of temozolomide increases
survival of rats with experimental glioblastoma. Mol Med Rep.
12:2828–2834. 2015.PubMed/NCBI
|
|
14
|
Studeny M, Marini FC, Dembinski JL,
Zompetta C, Cabreira-Hansen M, Bekele BN, Champlin RE and Andreeff
M: Mesenchymal stem cells: Potential precursors for tumour stroma
and targeted-delivery vehicles for anticancer agents. J Natl Cancer
Inst. 96:1593–1603. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Mooney R, Roma L, Zhao D, Van Haute D,
Garcia E, Kim SU, Annala AJ, Aboody KS and Berlin JM: Neural stem
cell-mediated intratumoural delivery of gold nanorods improves
photothermal therapy. ACS Nano. 8:12450–12460. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Kanojia D, Balyasnikova IV, Morshed RA,
Frank RT, Yu D, Zhang L, Spencer DA, Kim JW, Han Y, Yu D, et al:
Neural stem cells secreting anti-HER2 antibody improve survival in
a preclinical model of HER2 overexpressing breast cancer brain
metastases. Stem Cells. 33:2985–2994. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Pittenger MF: Mesenchymal stem cells from
adult bone marrow. Methods Mol Biol. 449:27–44. 2008.PubMed/NCBI
|
|
18
|
Paxinos G and Watson C: The Rat Brain in
Stereotaxic Coordinates. 6th. Academic Press; Cambridge, MA: pp.
1–456. 2007
|
|
19
|
Shipounova IN, Petinati NA, Bigildeev AE,
Zezina EA, Drize NI, Kuzmina LA, Parovichnikova EN and Savchenko
VG: Analysis of results of acute graft-versus-host disease
prophylaxis with donor multipotent mesenchymal stromal cells in
patients with hemoblastoses after allogeneic bone marrow
transplantation. Biochemistry (Mosc). 79:1363–1370. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Amson R, Karp JE and Telerman A: Lessons
from tumour reversion for cancer treatment. Curr Opin Oncol.
25:59–65. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Naaldijk Y, Johnson AA, Ishaka S, Meiseld
HJ, Hohausd C and Stolzingb A: Migrational changes of mesenchymal
stem cells in response to cytokines, growth factors, hypoxia and
aging. Exp Cell Res. 338:97–104. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Bryukhovetskiy IS, Bryukhovetskiy AS,
Mischenko PV and Khotimchenko YS: Role of systemic migration
mechanisms and stem cell homing in the development of malignant
tumours of the central nervous system and creating new methods of
antitumour therapy. Russian Biotherapeutic Journal. 4:3–12.
2013.(In Russian).
|
|
23
|
Herrera-Perez M, Voytik-Harbin SL and
Rickus JL: Extracellular matrix properties regulate the migratory
response of glioblastoma stem cells in three-dimensional culture.
Tissue Eng Part A. 21:2572–2582. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Sangar V, Funk CC, Kusebauch U, Campbell
DS, Moritz RL and Price ND: Quantitative proteomic analysis reveals
effects of epidermal growth factor receptor (EGFR) on
invasion-promoting proteins secreted by glioblastoma cells. Mol
Cell Proteomics. 13:2618–2631. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Formolo CA, Williams R, Gordish-Dressman
H, MacDonald TJ, Lee NH and Hathout Y: Secretome signature of
invasive glioblastoma multiforme. J Proteome Res. 10:3149–3159.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Walzlein JH, Synowitz M, Engels B,
Markovic DS, Gabrusiewicz K, Nikolaev E, Yoshikawa K, Kaminska B,
Kempermann G, Uckert W, et al: The antitumourigenic response of
neural precursors depends on subventricular proliferation and age.
Stem Cells. 26:2945–2954. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Miska J and Lesniak MS: Neural stem cell
carriers for the treatment of glioblastoma multiforme.
EBioMedicine. 2:774–775. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Neradil J and Veselska R: Nestin as a
marker of cancer stem cells. Cancer Sci. 106:803–811. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Furia L, Pelicci P and Faretta M: Confocal
microscopy for high-resolution and high-content analysis of the
cell cycle. Curr Protoc Cytom. 70:7.42.1–7.42.14. 2014. View Article : Google Scholar
|
|
30
|
Motaln H and Turnsek TL: Cytokines play a
key role in communication between mesenchymal stem cells and brain
cancer cells. Protein Pept Lett. 22:322–331. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Kidd S, Spaeth E, Dembinski JL, Dietrich
M, Watson K, Klopp A, Battula VL, Weil M, Andreeff M and Marini FC:
Direct evidence of mesenchymal stem cell tropism for tumour and
wounding microenvironments using in vivo bioluminescent imaging.
Stem Cells. 27:2614–2623. 2009. View
Article : Google Scholar : PubMed/NCBI
|
|
32
|
Moore XL, Lu J, Sun L, Zhu CJ, Tan P and
Wong MC: Endothelial progenitor cells' ‘homing’ specificity to
brain tumours. Gene Ther. 11:811–818. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Aboody KS, Najbauer J, Metz MZ, D'Apuzzo
M, Gutova M, Annala AJ, Synold TW, Couture LA, Blanchard S, Moats
RA, et al: Neural stem cell-mediated enzyme/prodrug therapy for
glioma: Preclinical studies. Sci Transl Med. 5:184ra592013.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Liu Y, Kobayashi A, Maeda T, Fu Q, Oikawa
M, Yang G, Konishi T, Uchihori Y, Hei TK and Wang Y: Target
irradiation induced bystander effects between stem-like and
non-stem-like cancer cells. Mutat Res. 773:43–47. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Chan JK and Lam PY: Human mesenchymal stem
cells and their paracrine factors for the treatment of brain
tumours. Cancer Gene Ther. 20:539–543. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Aboody KS, Brown A, Rainov NG, Bower KA,
Liu S, Yang W, Small JE, Herrlinger U, Ourednik V, Black PM, et al:
Neural stem cells display extensive tropism for pathology in adult
brain: Evidence from intracranial gliomas. Proc Natl Acad Sci USA.
97:12846–12851. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Bryukhovetskiy IS, Mischenko PV, Tolok EV,
Khotimchenko YS, Zaitcev SV and Bryukhovetskiy AS: Hematopoietic
stem cells with induced apoptosis effectively inhibit glioma cell
growth in vitro, but started new mechanism of tumour stem cells.
Genes and Cells. 9:70–75. 2014.
|
